المؤلفون: Lowenberg, B., Pabst, T., Maertens, J., Gradowska, P., Biemond, B.J., Spertini, O., Vellenga, E., Griskevicius, L., Tick, L.W., Jongen-Lavrencic, M., Kooy, M.V., Vekemans, M.C., van der Velden, W.J.F.M., Beverloo, B., Michaux, L., Graux, C., Deeren, D., de Weerdt, O., van Esser, J.W.J., Bargetzi, M., Klein, S.K., Gadisseur, A., Westerweel, P.E., Veelken, H., Gregor, M., Silzle, T., Van Lammeren-Venema, D., Moors, I., Breems, D.A., Hoogendoorn, M., Legdeur, M.C.J.C., Fischer, T., Kuball, J., Cornelissen, J., Porkka, K., Juliusson, G., Meyer, P., Hoglund, M., Gjertsen, B.T., Janssen, J.J.W.M., Huls, G., Passweg, J., Cloos, J., Valk, P.J.M., van Elssen, C.H.M.J., Manz, M.G., Floisand, Y., Ossenkoppele, G.J.

المصدر: Lowenberg , B , Pabst , T , Maertens , J , Gradowska , P , Biemond , B J , Spertini , O , Vellenga , E , Griskevicius , L , Tick , L W , Jongen-Lavrencic , M , Kooy , M V , Vekemans , M C , van der Velden , W J F M , Beverloo , B , Michaux , L , Graux , C , Deeren , D , de Weerdt , O , van Esser , J W J , Bargetzi , M , Klein , S K , Gadisseur ....

مصطلحات موضوعية: ACUTE MYELOID-LEUKEMIA, HIGH-DOSE LENALIDOMIDE, AZACITIDINE PLUS LENALIDOMIDE, MINIMAL RESIDUAL DISEASE, SEQUENTIAL AZACITIDINE, ELDERLY-PATIENTS, COMBINATION, CYTARABINE

الإتاحة: https://doi.org/10.1182/bloodadvances.2020003855Test
https://cris.maastrichtuniversity.nl/en/publications/3378c479-7c35-4be5-985d-98af71849a68Test

المؤلفون: Ossenkoppele, G. J., Breems, D. A., Stuessi, G., Van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., De Jongh, E., Klein, S. K., Van der Klift, M., Van Marwijk Kooy, M., Maertens, J., Micheaux, L., Van der Poel, M. W. M., Van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., Van der Velden, W. J. F. M., De Weerdt, O., Pabst, T., Manz, M., Lowenberg, B.

المصدر: Dutch-Belgian Hemato-Oncology , Swiss Grp Clinical Canc Res SAKK , Ossenkoppele , G J , Breems , D A , Stuessi , G , Van Norden , Y , Bargetzi , M , Biemond , B J , A von dem Borne , P , Chalandon , Y , Cloos , J , Deeren , D , Fehr , M , Gjertsen , B T , Graux , C , Huls , G , Janssen , J J J W , Jaspers , A , Jongen-Lavrencic , M , De Jongh , E , Klein , S K , ....

مصطلحات موضوعية: ACUTE MYELOID-LEUKEMIA, HIGH-DOSE LENALIDOMIDE, THERAPY, ADULTS

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/97f14b84-038f-45e9-8e79-0af373ddcd22Test

الإتاحة: https://doi.org/10.1038/s41375-020-0725-0Test
https://hdl.handle.net/11370/97f14b84-038f-45e9-8e79-0af373ddcd22Test
https://research.rug.nl/en/publications/97f14b84-038f-45e9-8e79-0af373ddcd22Test
https://pure.rug.nl/ws/files/118434471/Lenalidomide_added_to_standard_intensive_treatment_for_older_patients_with_AML_and_high_risk_MDS.pdfTest

المؤلفون: Ossenkoppele, G.J., Breems, D.A., Stuessi, G., Norden, Y. van, Bargetzi, M., Biemond, B.J., Borne, P.A. von dem, Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J.J.J.W., Jaspers, A., Jongen-Lavrencic, M., Jongh, E. de, Klein, S.K., Klift, M. van der, Kooy, M.V., Maertens, J., Micheaux, L., Poel, M.W.M. van der, Rhenen, A. van, Tick, L., Valk, P., Vekemans, M.C., Velden, W.J.F.M. van der, Weerdt, O. de, Pabst, T., Manz, M., Lowenberg, B., Havelange, Moors, I., Obberg, F. van, Maertens, J.A., Hodossy, B., Vansteenweghen, S., Lammertijn, L., Sonet, A., Triffet, A., Gjertsen, B.T., Passweg, J., Heim, D., Giovanni, S., Betticher, D., Spertini, O., Gregor, M., Hess, U., Manz, M.G., Loosdrecht, A. van de, Janssen, J.J.W.M., Esser, J.W.J. van, Brouwer, R.E., Lammeren-Venema, D. van, Levin, M.D., Tick, L.W., Legdeur, M.C.J.C., Vellenga, E., Hoogendoorn, M., Veelken, J.H., Schouten, H.C., Cornelissen, J., Wouters, B., Raaijmakers, H.G.M., Kuball, J., Dutch-Belgian Hemato-Oncology, Swiss Grp Clinical Canc Res SAKK

المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Clinical Haematology, CCA - Cancer Treatment and Quality of Life, CCA - Cancer Treatment and quality of life, Hematology laboratory, Hematology, Department of History, International Institute of Social Studies, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), UCL - SSS/DDUV - Institut de Duve, UCL - SSS/DDUV/MEXP - Médecine expérimentale, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (MGD) Service d'hématologie, UCL - (SLuc) Service d'hématologie

المصدر: Leukemia, 1751-1759. Nature Publishing Group
ISSUE=7;STARTPAGE=1751;ENDPAGE=1759;ISSN=0887-6924;TITLE=Leukemia
Leukemia, 34(7), 1751-1759. Nature Publishing Group
Leukemia, 34, 7, pp. 1751-1759
Ossenkoppele, G J, Breems, D A, Stuessi, G, van Norden, Y, Bargetzi, M, Biemond, B J, A von dem Borne, P, Chalandon, Y, Cloos, J, Deeren, D, Fehr, M, Gjertsen, B T, Graux, C, Huls, G, Janssen, J J J W, Jaspers, A, Jongen-Lavrencic, M, de Jongh, E, Klein, S K, Van der Klift, M, Van Marwijk Kooy, M, Maertens, J, Micheaux, L, van der Poel, M W M, Van Rhenen, A, Tick, L, Valk, P, Vekemans, M C, van der Velden, W J F M, de Weerdt, O, Pabst, T, Manz, M, Löwenberg, B & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) 2020, ' Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS ', Leukemia, vol. 34, no. 7, pp. 1751-1759 . https://doi.org/10.1038/s41375-020-0725-0Test
Leukemia, 34, 1751-1759. NATURE PUBLISHING GROUP
Leukemia, 34, 1751-1759
Leukemia, Vol. 34, no. 7, p. 1751-1759 (2020)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Phases of clinical research, HIGH-DOSE LENALIDOMIDE, ACUTE MYELOID-LEUKEMIA, THERAPY, 03 medical and health sciences, 0302 clinical medicine, Older patients, SDG 3 - Good Health and Well-being, Internal medicine, medicine, 610 Medicine & health, Adverse effect, Lenalidomide, Chemotherapy, business.industry, Intensive treatment, Myeloid leukemia, Hematology, ADULTS, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Cytarabine, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6afe4ddcbc8dbf30e80f1d9702e382dTest
https://research.rug.nl/en/publications/97f14b84-038f-45e9-8e79-0af373ddcd22Test

المؤلفون: Lowenberg, B., Pabst, T., Maertens, J., Gradowska, P., Biemond, B.J., Spertini, O., Vellenga, E., Griskevicius, L., Tick, L.W., Jongen-Lavrencic, M., Kooy, M.V., Vekemans, M.C., Velden, W.J.F.M. van der, Beverloo, B., Michaux, L., Graux, C., Deeren, D., Weerdt, O. de, Esser, J.W.J. van, Bargetzi, M., Klein, S.K., Gadisseur, A., Westerweel, P.E., Veelken, H., Gregor, M., Silzle, T., Lammeren-Venema, D. van, Moors, I., Breems, D.A., Hoogendoorn, M., Legdeur, M.C.J.C., Fischer, T., Kuball, J., Cornelissen, J., Porkka, K., Juliusson, G., Meyer, P., Hoglund, M., Gjertsen, B.T., Janssen, J.J.W.M., Huls, G., Passweg, J., Cloos, J., Valk, P.J.M., Elssen, C.H.M.J. van, Manz, M.G., Floisand, Y., Ossenkoppele, G.J., Dutch-Belgian Hemato-Oncology Coop, Swiss Grp Clinical Canc Res SAKK

المساهمون: Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Hematology, Clinical Genetics, Dutch-Belgian Hemato-Oncology Cooperative Group, Swiss Group for Clinical Cancer Research (SAKK), Internal medicine, VU University medical center, Hematology laboratory, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (MGD) Service d'hématologie, UCL - (SLuc) Service d'hématologie, Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Blood Adv
Blood advances, 5(4), 1110-1121. American Society of Hematology
Blood advances
Blood, 5(4), 1110-1121. American Society of Hematology
Löwenberg, B, Pabst, T, Maertens, J, Gradowska, P, Biemond, B J, Spertini, O, Vellenga, E, Griskevicius, L, Tick, L W, Jongen-Lavrencic, M, Kooy, M V M, Vekemans, M-C, van der Velden, W J F M, Beverloo, B, Michaux, L, Graux, C, Deeren, D, Weerdt, O D, Esser, J W J V, Klein, M B S K, Gadisseur, A, Westerweel, P E, Veelken, H, Gregor, M, Silzle, T, Lammeren-Venema, D Ë V, Moors, I, Breems, D A, Hoogendoorn, M, Legdeur, M-C J C, Fischer, T, Kuball, J, Porkka, J C K, Juliusson, G, Meyer, P, Höglund, M, Gjertsen, B T, Janssen, J J W M, Huls, G, Passweg, J, Cloos, J, Valk, P J M, Elssen, C H M J V, Manz, M G, Floisand, Y & Ossenkoppele, G J 2021, ' Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial ', Blood, vol. 5, no. 4, pp. 1110-1121 . https://doi.org/10.1182/bloodadvances.2020003855Test
BLOOD ADVANCES
Blood Advances, 5(4), 1110-1121. AMER SOC HEMATOLOGY
Blood Advances, 5, 1110-1121
Blood advances, 5(4), 1110-1121. The American Society of Hematology
Blood advances, Vol. 5, no. 4, p. 1110-1121 (2021)
Blood Advances, 5, 4, pp. 1110-1121
Blood, 5(4), 1110-1121. AMER SOC HEMATOLOGY
Blood advances, Washington : American Society of Hematology, 2021, vol. 5, no. 4, p. 1110-1121

مصطلحات موضوعية: Oncology, Clinical Trials and Observations, Phases of clinical research, 0302 clinical medicine, Autologous stem-cell transplantation, hemic and lymphatic diseases, Medicine and Health Sciences, ELDERLY-PATIENTS, Lenalidomide, LENALIDOMIDE, Remission Induction, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Chemotherapy regimen, 3. Good health, CYTARABINE, Leukemia, Myeloid, Acute, 030220 oncology & carcinogenesis, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Adolescent, HIGH-DOSE LENALIDOMIDE, MINIMAL RESIDUAL DISEASE, ACUTE MYELOID-LEUKEMIA, Transplantation, Autologous, 03 medical and health sciences, Young Adult, All institutes and research themes of the Radboud University Medical Center, SEQUENTIAL AZACITIDINE, Internal medicine, AZACITIDINE PLUS LENALIDOMIDE, AZACITIDINE PLUS, medicine, Humans, COMBINATION, Aged, Science & Technology, business.industry, Minimal residual disease, Transplantation, Regimen, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Cytarabine, Human medicine, business, 030215 immunology

وصف الملف: Print; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67b667f8652f65ff1c599befd9584961Test
https://pubmed.ncbi.nlm.nih.gov/33616652Test